DLA Piper and Morrison & Foerster have scored lead roles on the HK$4bn (£335m) sale of new shares by China's biggest drug distributor Sinopharm. The deal marks the second H share placement for Sinopharm since its $1.1bn (£714m) IPO in 2009, with 165.7 million shares being sold to between six and 10 non-retail investors at HK$24.60 (£2.06) each.
April 14, 2013 at 10:34 PM
1 minute read
The original version of this story was published on Legalweek
DLA Piper and Morrison & Foerster have scored lead roles on the HK$4bn (£335m) sale of new shares by China’s biggest drug distributor Sinopharm.
The deal marks the second H share placement for Sinopharm since its $1.1bn (£714m) IPO in 2009, with 165.7 million shares being sold to between six and 10 non-retail investors at HK$24.60 (£2.06) each.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
